通过放射性药物指导药物设计开发手术内成像剂的翻译蓝图
Teresa E Sullivan1, Servando Hernandez Vargas1, Sukhen C Ghosh1
1The Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA.
Current opinion in chemical biology
|August 12, 2023
概括
放射性药物正在转化为光剂,以改善手术期间的癌症检测. 这种方法通过利用现有的核医学工具来增强瘤可视化和手术精度.
科学领域:
- 分子成像学分子成像学
- 核医学是一种核医学.
- 手术瘤学手术瘤学
背景情况:
- 癌症成像正在推进新的分子标和敏感的检测技术.
- 核医学提供非侵入性的全身瘤可视化和监测.
- 光引导手术 (FGS) 提高了在手术室的瘤组织歧视.
研究的目的:
- 审查将放射性药物转化为光剂和多式联接剂的战略.
- 突出使用放射性药物作为FGS剂的模型的翻译潜力.
- 讨论基于放射性药物制剂的药剂设计所提供的独特能力.
主要方法:
- 对FGS的放射性药物转化现有文献的审查.
- 分析开发光和多式联通对应产品的战略.
- 检查这些药物的临床前和临床应用.
主要成果:
- 成功地将临床使用的放射性药物转化为光剂是可行的.
- 基于放射性药物的药剂为FGS提供了独特的优势.
- 多模式药物结合了成像和治疗能力.
结论:
- 将放射性药物转化为光剂对FGS具有显著的翻译潜力.
- 这种方法利用已建立的核医学专业知识进行手术指导.
- 基于放射性药物的设计使先进的临床前和临床癌症成像成为可能.
相关概念视频
01:28Structure-Activity Relationships and Drug Design
769
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
769
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
156
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
156